Eleanor Mitchell

Contact

• workRoom Nottingham Clinical Trials Unit Nottingham Health Science Partners
  Queen's Medical Centre
  Nottingham
  NG7 2UH
  UK
• work0115 8844926
• fax0115 9194430
• eleanor.mitchell@nottingham.ac.uk

Biography

Eleanor is the Trial Manager for the STOP GAP Trial, which is a multi-centre trial (approx. 50 sites) investigating treatments for Pyoderma Gangrenosum. She is based in the Nottingham Clinical Trials Unit at the Queen's Medical Centre, where the study is being coordinated. She joined CEBD in 2008 having previously worked in clinical research for eight years as a Project Co-ordinator and Research Manager for Academic Rheumatology at the University of Nottingham. During this time she managed a large gene-environmental interaction study for patients with osteoarthritis, and oversaw a variety of epidemiological studies and trials. She has also completed a degree in Business Studies, whilst she was based in Rheumatology.

Research Summary

Currently managing a five year clinical trial as part of a NIHR programme grant awarded to the Centre of Evidence Based Dermatology, investigating treatments for pyoderma gangrenosum, a rare,… read more

Recent Publications

• CRAIG FF, THOMAS KS, MITCHELL EJ, WILLIAMS HC, NORRIE J, MASON JM and ORMEROD AD, 2012. Uk dermatology clinical trials network's stop gap trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials. 13(1), 51 (In Press.)
• MITCHELL E: ON BEHALF OF THE STOP GAP TRIAL MANAGEMENT GROUP, 2010. RCT of treatments for pyoderma gangrenosum: time to get involved Wounds UK. 6(4), 27-32
• MITCHELL E, 2010. Do you see patients with pyoderma gangrenosum? If so, consider referral to STOP GAP trial Leg Ulcer Forum Journal. 24 - Autumn 2010, 46-48

• View all publications

Current Research

Currently managing a five year clinical trial as part of a NIHR programme grant awarded to the Centre of Evidence Based Dermatology, investigating treatments for pyoderma gangrenosum, a rare, inflammatory, ulcerating skin condition. The trial aims to recruit 140 patients by October 2012 across approximately 50 hospitals in the UK and Ireland. More details about the trial can be found at www.stopgaptrial.co.uk.

Past Research

Research Manager in the Division of Academic Rheumatology at the University of Nottingham, working closely with Professor Michael Doherty. Involved in managing a variety of research projects, including a clinical trial investigating knee pain and various epidemiological studies.

Project Co-ordinator of the GOAL Study (Genetics of Osteoarthrtitis and Lifestyle), which was a 4-year gene-environmental interaction study, recruiting patients with knee and hip osteoarthritis and age/gender-matched control subjects. Over 3000 participants were recruited into this study.

• CRAIG FF, THOMAS KS, MITCHELL EJ, WILLIAMS HC, NORRIE J, MASON JM and ORMEROD AD, 2012. Uk dermatology clinical trials network's stop gap trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials. 13(1), 51 (In Press.)
• MITCHELL E: ON BEHALF OF THE STOP GAP TRIAL MANAGEMENT GROUP, 2010. RCT of treatments for pyoderma gangrenosum: time to get involved Wounds UK. 6(4), 27-32
• MITCHELL E, 2010. Do you see patients with pyoderma gangrenosum? If so, consider referral to STOP GAP trial Leg Ulcer Forum Journal. 24 - Autumn 2010, 46-48